Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)

China flag China · Delayed Price · Currency is CNY
65.98
-2.96 (-4.29%)
At close: Mar 9, 2026
42.97%
Market Cap 4.40B
Revenue (ttm) 336.73M
Net Income (ttm) 101.91M
Shares Out 66.70M
EPS (ttm) 1.54
PE Ratio 42.81
Forward PE n/a
Dividend 0.60 (0.87%)
Ex-Dividend Date May 30, 2025
Volume 1,173,156
Average Volume 1,172,551
Open 67.62
Previous Close 68.94
Day's Range 65.22 - 67.68
52-Week Range 41.40 - 92.50
Beta -0.02
RSI 36.21
Earnings Date Apr 28, 2026

About SHE:301033

Medprin Regenerative Medical Technologies Co., Ltd. engages in the research, development, manufacture, and sale of implantable medical devices. The company offers artificial dura matermembrane patches, craniomaxillofacial repair and fixation systems, and absorbable regenerative oxidation for neurosurgery meningeal repair, skull repair fixation and rapid hemostasis, etc. It also offers ReDura, a Synthetic Dural Substitute; NeoDura, a novel dural patch; Recranio, a Cranio-Maxillofacial repair system; and StypCel, an Absorbable Hemostat; Immiseal,... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2008
Employees 337
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301033
Full Company Profile

Financial Performance

In 2024, SHE:301033's revenue was 278.44 million, an increase of 20.61% compared to the previous year's 230.87 million. Earnings were 78.85 million, an increase of 92.90%.

Financial Statements

News

There is no news available yet.